APA (7th ed.) Citation

I, F., Z, I., A, d. V., M, R., EF, V., JG, O., . . . MÁ, G. (2025). ADAMTS13 and insulin resistance in systemic sclerosis patients. Clinical and experimental rheumatology, 43(8), 1422. https://doi.org/10.55563/clinexprheumatol/az2scd

Chicago Style (17th ed.) Citation

I, Ferraz-Amaro, Ibrahim-Achi Z, de Vera-González A, Renuncio-García M, Vicente-Rabaneda EF, Ocejo-Vinyals JG, Castañeda S, and González-Gay MÁ. "ADAMTS13 and Insulin Resistance in Systemic Sclerosis Patients." Clinical and Experimental Rheumatology 43, no. 8 (2025): 1422. https://doi.org/10.55563/clinexprheumatol/az2scd.

MLA (9th ed.) Citation

I, Ferraz-Amaro, et al. "ADAMTS13 and Insulin Resistance in Systemic Sclerosis Patients." Clinical and Experimental Rheumatology, vol. 43, no. 8, 2025, p. 1422, https://doi.org/10.55563/clinexprheumatol/az2scd.